Member Info for gggg21

You just don’t look at rns or company info Neil though no? As you didn’t know that Synairgen trial had been competed or that it was only in specific hospitals….this from a shareholder of two years you said. Astounded really two years and you know basically nothing about the company. As you were

So in the last hour just announced that Biden has doubled the original order of the Pfizer pill, and trying to bring more pills in even though most not to be delivered until summer. Stockpiling begins. Think this overall order just for US worth over $5bn

https://www.bloomberg.com/news/articles/2022-01-04/pfizer-says-u-s-to-buy-10-million-more-courses-of-covid-pill

Lol only two weeks ago surely you would have known as a Shareholder for so long neil that the trial has finished and was at specific hospitals…..

Exactly why i post less and less these days, obvious as can be how andy et all turn up at same time saying they sold, trolling, just posting rubbish basically, i mean you got brooking saying he will be out for results but then a post later says he will buy back at 190....today has been good for ftse majors and oilers, but markets will again be circular and come back. In mean time day closer to readout, US hospital cases at highest numbers in nearly a year and polygon hold 16% and were happy to pay well over 200. Have a good evening

the trial is designed to give best results, this is why you run p1 and p2 trials so the odds are very much in favour....on the good results you may be lucky to get back in around £4 in reality as will be in auction with orders and funds buying the gap up, it will be all over every news channel and probably mention EUA FDA application

only new bit i see is confirmation they recruited 88 people from india on the trial out of the 610 globally

http://ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53300&EncHid=&userName=SNG001

Updated last night and shown as completed now, looks like house being put in order, can't make out if anything has changed...

You could even go further with the ethnicity etc as BAM have been more likely to be hospitalised from Covid. Given the US has a higher proportion of BAM demographic than uk, again another potential statistical point that could be considered in the evaluation. All of which is no bad thing if it improves the odds overall of better stats/results in US

My take (maybe a little left field perhaps) is that i would expect results to be statistically better in the US for trials. DDDD has statistical better results for one of their trials in US when compared to UK and they contributed this to lifestyle/general health of the US average person in terms of BMI etc compared to UK. I think this will be similar with synairgen as the obesity levels in US (which does cause higher risk with covid etc) are higher.....

Think I’m going to have some melon for breakfast

Well we already know some staff have been on overseas business trips very recently for very specific reasons ;)

We are seriously entering the end game now! have a great new years all the usual here.

In auction in France now. Go again tomorrow. Excellent

It’s still trading 482 11% up. Hope nobody listened to woody and his imaginary friend the other day would have lost money listening to those truck drivers at the “spoons”

Ummmm https://www.lse.co.uk/rns/NCYT/half-year-2021-results-25htu0dw34gr5u4.html
Half year revenue broken down
UK 20.9m
Europe 20.2m
US 4.9m

Sooooo given france is in europe and spain cases rising rapid etc like france.....then....yeh sales ok.
US made up 10% of half year revenue....so again....yeh ok and sales team increased over there....

https://www.aljazeera.com/news/2021/12/22/singapore-suspends-quarantine-free-travel-live-updates

Their booster roll out well behind UK and hospital numbers rising now there. Spain is going to become a worry. US covid cases are soaring to thier booster campaign stands at 18% vs uk at 48% now

as money is chasing those stocks, circular market, even i took a trade in avacta for a xmas bonus, sellers will clear out of those stocks and then novacyt will move up again.

Yeh nothing to worry about at all. 59k cases last tuesday now near 90k cases this tuesday.....and people sell....

and we have seen the push for winterplex from a few US suppliers....getting full approval for that would be a nice bonus

https://bidstats.uk/tenders/2021/W50/765002125

This should be right up novacyt street given the escaplex and all the millions of sequencing they have done and analysis. Wonder how much the end values will be